These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 3602014

  • 1. The role of haemorheological factors in the ageing brain: long-term therapy with pentoxifylline ('Trental' 400) in elderly patients with initial mental deterioration.
    Parnetti L, Ciuffetti G, Mercuri M, Lupattelli G, Senin U.
    Pharmatherapeutica; 1986; 4(10):617-27. PubMed ID: 3602014
    [Abstract] [Full Text] [Related]

  • 2. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
    Reilly DT, Quinton DN, Barrie WW.
    N Z Med J; 1987 Jul 22; 100(828):445-7. PubMed ID: 3330188
    [Abstract] [Full Text] [Related]

  • 3. Effects of long-term treatment (4 years) with pentoxifylline on haemorheological changes and vascular complications in diabetic patients.
    Ferrari E, Fioravanti M, Patti AL, Viola C, Solerte SB.
    Pharmatherapeutica; 1987 Jul 22; 5(1):26-39. PubMed ID: 3602021
    [Abstract] [Full Text] [Related]

  • 4. Haemorheological pattern in initial mental deterioration: results of a long-term study using piracetam and pentoxifylline.
    Parnetti L, Ciuffetti G, Mercuri M, Senin U.
    Arch Gerontol Geriatr; 1985 Jul 22; 4(2):141-55. PubMed ID: 3899033
    [Abstract] [Full Text] [Related]

  • 5. Some haemorheological factors in patients with arteriosclerosis obliterans after treatment of trental.
    Chyzy R, Lukjan H, Rość D, Bielawiec M, Sawicka J.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987 Jul 22; 114(4):549-54. PubMed ID: 2446996
    [Abstract] [Full Text] [Related]

  • 6. The haemorheological and antithrombotic potential of pentoxifylline ('Trental'): a review.
    Schönharting M, Musikić P, Müller R.
    Pharmatherapeutica; 1988 Jul 22; 5(3):159-69. PubMed ID: 3283776
    [Abstract] [Full Text] [Related]

  • 7. Cerebral blood flow under hypobaric conditions: effects of pentoxifylline ('Trental' 400).
    Koppenhagen K.
    Pharmatherapeutica; 1984 Jul 22; 4(1):1-5. PubMed ID: 6504944
    [Abstract] [Full Text] [Related]

  • 8. Pentoxifylline (Trental) has no significant effect on laboratory parameters in sickle cell disease.
    Billett HH, Kaul DK, Connel MM, Fabry ME, Nagel RL.
    Nouv Rev Fr Hematol (1978); 1989 Jul 22; 31(6):403-7. PubMed ID: 2694097
    [Abstract] [Full Text] [Related]

  • 9. [Indications for using trental in the initial manifestations of inadequate blood supply to the brain].
    Eninia GI, Egere DA, Robule VKh, Maĭore IKh.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986 Jul 22; 86(1):50-2. PubMed ID: 3953193
    [Abstract] [Full Text] [Related]

  • 10. Cerebral blood flow in patients with cerebrovascular disorders: study with pentoxifylline.
    Hartmann A.
    Ric Clin Lab; 1981 Jul 22; 11 Suppl 1():243-6. PubMed ID: 7188111
    [Abstract] [Full Text] [Related]

  • 11. Results of clinical, laboratory and haemorheological investigations of the use of pentoxifylline in high doses.
    Antignani PL, Todini AR, Saliceti F, Pacino G, Bartolo M.
    Pharmatherapeutica; 1987 Jul 22; 5(1):50-6. PubMed ID: 3602022
    [Abstract] [Full Text] [Related]

  • 12. Comparative randomized study of cerebral blood flow after long-term administration of pentoxifylline and co-dergocrine mesylate in patients with chronic cerebrovascular disease.
    Hartmann A.
    Curr Med Res Opin; 1985 Jul 22; 9(7):475-9. PubMed ID: 4028808
    [Abstract] [Full Text] [Related]

  • 13. On the assessment of the efficacy of pentoxifylline (Trental).
    Rössner M, Müller R.
    J Med; 1987 Jul 22; 18(1):1-15. PubMed ID: 3298515
    [Abstract] [Full Text] [Related]

  • 14. [Pentoxifylline and arterial hypertension in diabetes mellitus: long-term results in randomized groups].
    Solerte SB, Adamo S, Viola C, Zambianchi E, Ferrari E.
    Ric Clin Lab; 1985 Jul 22; 15 Suppl 1():515-26. PubMed ID: 4035232
    [Abstract] [Full Text] [Related]

  • 15. Controlled clinical trial of pentoxifylline versus cinnarizine in the treatment of labyrinthine disorders.
    Ganança MM, Mangabeira Albernaz PL, Caovilla HH, Ito YI.
    Pharmatherapeutica; 1988 Jul 22; 5(3):170-6. PubMed ID: 3283777
    [Abstract] [Full Text] [Related]

  • 16. Pentoxifylline -- a biomedical profile.
    Müller R.
    J Med; 1979 Jul 22; 10(5):307-29. PubMed ID: 393789
    [Abstract] [Full Text] [Related]

  • 17. Amelioration of blood viscosity in sickle cell anemia by pentoxifylline. A case report.
    Keller F, Leonhardt H.
    J Med; 1979 Jul 22; 10(6):429-33. PubMed ID: 299452
    [Abstract] [Full Text] [Related]

  • 18. Placebo controlled double-blind study of pentoxifylline in sickle cell disease patients.
    Manrique RV.
    J Med; 1987 Jul 22; 18(5-6):277-91. PubMed ID: 3333162
    [Abstract] [Full Text] [Related]

  • 19. Effect of pentoxifylline on regional cerebral blood flow in patients with cerebrovascular disease.
    Hartmann A.
    Pharmatherapeutica; 1981 Jul 22; 2(8):528-31. PubMed ID: 7255509
    [Abstract] [Full Text] [Related]

  • 20. [The blood rheological indices of patients with necrobiosis lipoidica].
    Petrova GA, Levin GIa.
    Vestn Dermatol Venerol; 1989 Jul 22; (12):45-8. PubMed ID: 2633553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.